FRASCATANI, RACHELE
FRASCATANI, RACHELE
Dipartimento di Medicina dei sistemi
Bromodomain-containing 4 as a therapeutic target in inflammatory bowel diseases and colorectal cancer
2025-01-01 Marafini, I; Frascatani, R; Colella, M; De Cristofaro, E; Monteleone, G
Bromodomain-Containing 4 Is a Positive Regulator of Interleukin-34 Production in the Gut
2024-01-01 Franzè, E; Laudisi, F; Frascatani, R; Tomassini, L; DE CRISTOFARO, E; Stolfi, C; Monteleone, G
Bromodomain-containing protein 4 in inflammatory diseases: molecular mechanisms and therapeutic potential
2026-01-01 Frascatani, R; Marafini, I; Colella, M; Monteleone, G
Circulating Hepcidin Levels Are an Independent Predictor of Survival in Microsatellite Stable Metastatic Colorectal Cancer Patient Candidates for Standard First-Line Treatment
2024-01-01 Formica, V; DI GRAZIA, A; Bonomo, Mv; Frascatani, R; Mancone, R; Monteleone, G
Hepcidin Is a Valuable Therapeutic Target for Colorectal Cancer
2024-01-01 Frascatani, R; Colella, M; Monteleone, G
High Smad7 marks inflammation in patients with chronic pouchitis
2025-03-03 Maresca, C; Iannucci, A; Colella, M; Frascatani, R; Laudisi, F; Lolli, E; Marafini, I; Zorzi, F; Salvatori, S; Monteleone, I; Bellinvia, S; Stolfi, C; Monteleone, G
Immunologic Drivers and Restraints in Colitis-Associated Colorectal Cancer
2026-01-01 Frascatani, R; Laudisi, F; Stolfi, C; Monteleone, G
Longitudinal Evidence of Sustained Taurine Deficiency in Inflammatory Bowel Disease
2026-01-01 Frascatani, R; Mattogno, A; Salvatori, S; Iannucci, A; Marafini, I; Monteleone, G
Loss of Adenosine Deaminase Acting on RNA 1 Induces Panoptosis and Immune Response in Ulcerative Colitis Gut Mucosa
2025-06-01 Iannucci, A; Colella, M; Quiroga, M; Frascatani, R; Tomassini, L; Maresca, C; Franzè, E; Laudisi, F; Sica, G; Marafini, I; Michienzi, A; Zanoni, I; Monteleone, G; Monteleone, I
Reduced Taurine Serum Levels in Inflammatory Bowel Disease
2024-01-01 Frascatani, R; Mattogno, A; Iannucci, A; Marafini, I; Monteleone, G
Smad7 is a negative regulator of immunogenic cell death in colorectal cancer
2025-01-01 Maresca, C; Franzè, E; Laudisi, F; Colella, M; Iannucci, A; Frascatani, R; Monteleone, I; Stolfi, C; Monteleone, G
Targeting hepcidin in colorectal cancer triggers a TNF-dependent-gasdermin E-driven immunogenic cell death response
2024-09-27 Di Grazia, A; Franzè, E; Frascatani, R; Laudisi, F; Pacifico, T; Tomassini, L; Di Fusco, D; Formica, V; Sica, G; Stolfi, C; Monteleone, I; Monteleone, G
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-2025 | Bromodomain-containing 4 as a therapeutic target in inflammatory bowel diseases and colorectal cancer | Marafini, I; Frascatani, R; Colella, M; De Cristofaro, E; Monteleone, G | Articolo su rivista | |
| 1-gen-2024 | Bromodomain-Containing 4 Is a Positive Regulator of Interleukin-34 Production in the Gut | Franzè, E; Laudisi, F; Frascatani, R; Tomassini, L; DE CRISTOFARO, E; Stolfi, C; Monteleone, G | Articolo su rivista | |
| 1-gen-2026 | Bromodomain-containing protein 4 in inflammatory diseases: molecular mechanisms and therapeutic potential | Frascatani, R; Marafini, I; Colella, M; Monteleone, G | Articolo su rivista | |
| 1-gen-2024 | Circulating Hepcidin Levels Are an Independent Predictor of Survival in Microsatellite Stable Metastatic Colorectal Cancer Patient Candidates for Standard First-Line Treatment | Formica, V; DI GRAZIA, A; Bonomo, Mv; Frascatani, R; Mancone, R; Monteleone, G | Articolo su rivista | |
| 1-gen-2024 | Hepcidin Is a Valuable Therapeutic Target for Colorectal Cancer | Frascatani, R; Colella, M; Monteleone, G | Articolo su rivista | |
| 3-mar-2025 | High Smad7 marks inflammation in patients with chronic pouchitis | Maresca, C; Iannucci, A; Colella, M; Frascatani, R; Laudisi, F; Lolli, E; Marafini, I; Zorzi, F; Salvatori, S; Monteleone, I; Bellinvia, S; Stolfi, C; Monteleone, G | Articolo su rivista | |
| 1-gen-2026 | Immunologic Drivers and Restraints in Colitis-Associated Colorectal Cancer | Frascatani, R; Laudisi, F; Stolfi, C; Monteleone, G | Articolo su rivista | |
| 1-gen-2026 | Longitudinal Evidence of Sustained Taurine Deficiency in Inflammatory Bowel Disease | Frascatani, R; Mattogno, A; Salvatori, S; Iannucci, A; Marafini, I; Monteleone, G | Articolo su rivista | |
| 1-giu-2025 | Loss of Adenosine Deaminase Acting on RNA 1 Induces Panoptosis and Immune Response in Ulcerative Colitis Gut Mucosa | Iannucci, A; Colella, M; Quiroga, M; Frascatani, R; Tomassini, L; Maresca, C; Franzè, E; Laudisi, F; Sica, G; Marafini, I; Michienzi, A; Zanoni, I; Monteleone, G; Monteleone, I | Articolo su rivista | |
| 1-gen-2024 | Reduced Taurine Serum Levels in Inflammatory Bowel Disease | Frascatani, R; Mattogno, A; Iannucci, A; Marafini, I; Monteleone, G | Articolo su rivista | |
| 1-gen-2025 | Smad7 is a negative regulator of immunogenic cell death in colorectal cancer | Maresca, C; Franzè, E; Laudisi, F; Colella, M; Iannucci, A; Frascatani, R; Monteleone, I; Stolfi, C; Monteleone, G | Articolo su rivista | |
| 27-set-2024 | Targeting hepcidin in colorectal cancer triggers a TNF-dependent-gasdermin E-driven immunogenic cell death response | Di Grazia, A; Franzè, E; Frascatani, R; Laudisi, F; Pacifico, T; Tomassini, L; Di Fusco, D; Formica, V; Sica, G; Stolfi, C; Monteleone, I; Monteleone, G | Articolo su rivista |